Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.51%||64.80||1.0%||$543.24m|
|VRTX||Vertex Pharmaceuticals, Inc.||1.51%||273.73||1.9%||$497.98m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.37%||692.80||2.6%||$444.80m|
|SNSS||Sunesis Pharmaceuticals, Inc.||2.38%||2.15||0.7%||$150.29m|
|EXAS||EXACT Sciences Corp.||7.96%||53.83||17.7%||$134.25m|
|TXG||10X Genomics, Inc.||11.91%||52.99||0.0%||$106.79m|
|BMRN||BioMarin Pharmaceutical, Inc.||2.68%||80.97||4.2%||$95.42m|
|CRSP||CRISPR Therapeutics AG||5.63%||58.34||0.6%||$85.42m|
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.